---
schema_version: "secwatch.filing_event.v1"
accession: "0001822479-24-000046"
form_type: "8-K"
ticker: "SHC"
cik: "0001822479"
company_name: "Sotera Health Co"
filed_at: "2024-11-05T23:59:59+00:00"
generated_at: "2026-05-30T05:27:17.831202+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: "high"
source: SEC EDGAR
---

# Sotera Health Q3 net rev $285M (+8.5% YoY); net income $17M vs loss $14M; reaffirms FY outlook

## Summary
- Q3 net revenues $285M, up 8.5% YoY (8.9% constant currency); net income $17M ($0.06 diluted) vs net loss $14M in Q3 2023.
- Adjusted EBITDA $146M, +9.0% YoY; Adjusted EPS $0.17, +$0.01 YoY.
- Nine-month 2024 net revenues $810M (+9.6% YoY); net income $32M ($0.11 diluted) vs $13M prior year.
- Reaffirming 2024 net revenue and Adjusted EBITDA outlook ranges.
- CEO cites Nordion cobalt-60 timing benefit; investor day planned for Nov 20, 2024 in NYC.

## SEC filing metadata
- accession: 0001822479-24-000046
- form_type: 8-K
- ticker: SHC
- cik: 0001822479
- company_name: Sotera Health Co
- filed_at: 2024-11-05T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.65
- calibrated_materiality_score: 0.65
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1822479/000182247924000046/0001822479-24-000046-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1822479/000182247924000046/shc-20241105.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001822479-24-000046
- JSON: https://secwatch.observer/filing/0001822479-24-000046.json
- Plain text: https://secwatch.observer/filing/0001822479-24-000046.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.